These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19911483)

  • 1. Drug treatment. Companies fail to develop innovative HIV drugs, group says.
    AIDS Policy Law; 2009 Oct; 24(11):3. PubMed ID: 19911483
    [No Abstract]   [Full Text] [Related]  

  • 2. Teaming up to provide HIV drugs to patients.
    AIDS Alert; 2010 Jul; 25(7):82. PubMed ID: 20806791
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence strategies. ASO's collaborate with medical providers. Services help patients improve adherence.
    AIDS Alert; 2008 Dec; 23(12):137-9. PubMed ID: 19110684
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipeline update: short notes on new anti-HIV drugs in development.
    Proj Inf Perspect; 2006 Oct; (42):11-6. PubMed ID: 17162806
    [No Abstract]   [Full Text] [Related]  

  • 5. WORLD's HIV University is not alone.
    Heitzman KJ
    WORLD; 1999 Nov; (No 103):7. PubMed ID: 11366861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A visit to India: drug prices, research, & global access.
    Scondras D
    AIDS Treat News; 1999 Jan; (No 311):6-8. PubMed ID: 11366155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fine line between education and marketing.
    Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IAPAC proposes rationing HIV drugs in the U.S. International Association of Physicians in AIDS Care.
    AIDS Alert; 1998 Jan; 13(1):9-10. PubMed ID: 11364866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What the world needs now. New HIV drugs for the next decade.
    Huff B
    Posit Aware; 2007; 18(2):30-2. PubMed ID: 17390488
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral misuse in Mumbai, India.
    Chinai R
    Bull World Health Organ; 2003; 81(2):153. PubMed ID: 12751427
    [No Abstract]   [Full Text] [Related]  

  • 11. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-prevention program fails rape survivors in Africa, group says.
    AIDS Policy Law; 2004 Apr; 19(7):4. PubMed ID: 15124597
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress against HIV.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT27-9. PubMed ID: 11221711
    [No Abstract]   [Full Text] [Related]  

  • 14. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1.
    Huther A; Dietrich U
    AIDS Rev; 2007; 9(4):208-17. PubMed ID: 18219364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobias, W.H.O. at odds over drug standards.
    Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons in hope.
    Proj Inf Perspect; 2006 Jan; (40):1-5. PubMed ID: 16718903
    [No Abstract]   [Full Text] [Related]  

  • 17. Prisons. Inmate deprived of HIV drugs during lockdown loses suit.
    AIDS Policy Law; 2004 Aug; 19(16):6. PubMed ID: 15473032
    [No Abstract]   [Full Text] [Related]  

  • 18. Collaboration studies co-receptor drug research.
    AIDS Patient Care STDS; 1998 Mar; 12(3):230. PubMed ID: 11361940
    [No Abstract]   [Full Text] [Related]  

  • 19. Report: treatment, drug access for MSM still poor.
    AIDS Policy Law; 2008 Sep; 23(10):2. PubMed ID: 18814361
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare D has big impact on HIV treatment interruptions. Decreased access to meds, six-fold increase in interruptions.
    AIDS Alert; 2008 Nov; 23(11):121-3. PubMed ID: 19043865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.